This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found by clicking on the sponsors tab.

Agenda

Speakers

About

NCC, Birmingham | 19-20 November 2025

We are delighted to invite you to attend this year’s National Primary Care Diabetes & Obesity (PCDO) Society, our annual free-to-attend, two day conference taking place on 19-20 November 2025 in Birmingham.

We are pleased to be meeting face to face in Birmingham and as ever, you will be able to benefit from clinically focused education on a range of topics that are most relevant to the practicalities of managing diabetes and obesity in primary care today. Printed and online materials will allow you to use your learning experience towards your CPD. In addition, breaks during the day will also allow the perfect opportunity for networking with your colleagues.

We very much hope you can join us for this key event in the 2025 diabetes and obesity calendar.

Why attend

Masterclasses offering hands-on tips that will influence your everyday clinical practice

Inspiration and new contacts with various opportunities to network alongside your peers

Claim 12 CPD points for the two-day conference, and receive a workbook to build your CPD profile, supplemented by associated online materials

Agenda

Day 1:

19 November 2025 09.00 - 17.20

Agenda

08.20 – 09.00

Registration and refreshments

09.00 – 09.30

NHS England update and Q&A

New pathways and guidance
Obesity drugs in primary care
Resources for HCPs and patients

Clare Hambling & Naresh Kanumilli

09.30 – 10.10

Going with the FLOW: Diagnosing and managing adults with type 2 diabetes and chronic kidney disease in primary care

This promotional session is organised and funded by Novo Nordisk Ltd. and is intended for UK healthcare professionals only. Novo Nordisk products will be discussed.

UK25OZM00311 | November 2025

Join us for a discussion on the findings from the FLOW study and the role of Ozempic® (semaglutide injection) in the management of people with type 2 diabetes (T2D) and chronic kidney disease (CKD).

Objectives:

Discuss the interrelation of cardiovascular-renal-metabolic disease and the rising prevalence of diabetes
Understand the definition and staging of CKD and how it affects and is affected by T2D
Understand the clinical benefits of Ozempic® for the treatment of adults living with T2D and CKD
Review the safety and practical information to consider when using Ozempic®

Ozempic® (semaglutide injection) Prescribing and Adverse Event Reporting Information can be found here: https://www.emcpi.com/grp/19

Dr Yassir Javaid (Chair) & Professor James Burton

10.10 – 10.45

Debate: What is more important – the Heart or the Kidneys?

How are they interconnected?
When do we need to prioritise one over the other?
How can we protect both?

Paul Kalra & Philip Kalra

10.45 – 11.15

Refreshments

11.15 – 12.00

Masterclass rotation 1:

Masterclass 1: Having the obesity conversation: the patient’s view – Sarah le Brocq

Raising weight issues: When and how
Minimising weight bias and stigma
What matters most to our patients?

Masterclass 2: Complex cases – David Morris

This session looks at diagnostically challenging cases of diabetes presenting in primary care.
When should alternative diagnoses to type 2 diabetes be considered?
How can we identify autoimmune diabetes, MODY and pancreatogenic diabetes so that these conditions can be optimally managed?
What should our approach to management of the younger non-overweight/obese person diagnosed with diabetes be?

Masterclass 3: Women’s health in diabetes – Lisa Owens & Nicola Milne

Menopause and HRT
Female sexual dysfunction
PCOS, contraception and pre-conception

Masterclass 4: “Missed but not forgotten” – Professor Kate O’Donnell

The consequences of missing data
Managing hard-to-reach populations
Increasing engagement

Various

12.00 – 13.00

Lunch

13.00 – 13.10

Poster results

13.10 – 13.20

Lifetime Achievement Award presented to new winner

Su Down

13.20 – 14.00

Delivering Change: Service Developments to Combat CKD

This promotional symposium session is developed and funded by Boehringer Ingelheim for UK HCPs only. Boehringer Ingelheim products will be discussed at this meeting. Boehringer Ingelheim has provided funding towards the Primary Care Diabetes & Obesity Society Conference 2025; however, it has had no input into the agenda, speaker selection, presentations, or collateral content, except for this promotional symposium session, which the Boehringer Ingelheim are fully responsible for.

PC-GB-112057 | September 2025

Stephen Wheatcroft (Chair), Niraj Lakhani, Saqib Mughal & Harsha Wodeyar

14.00 – 14.05

Move to masterclasses

14:05 – 14.50

Masterclass rotation 2:

See list of masterclasses above

Various

14.50 – 15.20

Refreshments

15.20 – 15.50

Lifestyle medicine

Diet
Physical activity
Sleep
Stress

Sheena Fraser

15.50 – 16.30

Use of Diabetes Technology in Early Onset Type 2 Diabetes

This session has been organised and funded by Dexcom

James Ridgeway

16.30 – 17.05

A decade of diabetes at NHS England: From Mowgli to Bagheera

What he’s learned, what’s changed and what’s to come

Partha Kar

17.05 – 17.20

AGM

Day 2:

20 November 2025 09.00 - 16.00

Agenda

08.30 – 09.00

Registration and refreshments

09.00 – 09.35

Redefining obesity: Clinical vs pre-clinical obesity

Definitions of clinical and pre-clinical obesity
Assessing obesity complications and comorbidities
Is this a useful distinction in real-life practice?

Clare Hambling & Naresh Kanumilli

09.35 – 10.10

Discontinuation of Levemir® (insulin detemir): How to respond

Case-finding and clinical review
Who to prioritise
Choosing an appropriate new insulin
Avoiding glucose instability when switching

Clair Ranns & Waqas Tahir

10.10 – 10.50

Why iCGM matters: Beyond CE marking and MARD

This session has been organised and supported by Abbott Laboratories Ltd

John Pemberton

10.50 – 11.20

Refreshments

11.20 – 12.05

Masterclass rotation 1:

Masterclass 1: Implementation of obesity guidelines – Dimitris Papamargaritis

Take-home messages from NICE and NHS guidance
Weight-loss drugs: Who is eligible?
Lifestyle resources and signposting
Overcoming resistance in your locality

Masterclass 2: Diet advice: Separating fact from fiction – Sarah Alicea

Which diet is best?
Time-restricted eating
The ZOE effect
Mythbusting

Masterclass 3: Liver tests in type 2 diabetes: What and when? – Prof Guru Aithal

Interpreting liver function tests
Identifying different types of fatty liver disease
Identifying and referring for fibrosis

Masterclass 4: Tech – What do we need to know in primary care? – David Miller

Continuous glucose monitoring: What, who and when?
Essentials of data interpretation
Hybrid-closed-loop systems
Data privacy, driving and other medicolegal issues

Various

12.05 – 12.10

Masterclass change around

12.10 – 12.55

Masterclasses repeated as above.

Various

12.55 – 13.55

Lunch

13.55 – 14.10

LAA presentation – Future insights and treatments in diabetes: Abstracts and posters from the ADA conference

New diabetes and obesity drugs
New technologies

Neil Munro

14.10 – 14.50

Type 2 Diabetes and Obesity Care: Learnings from Real Life Cases

This is a promotional symposium developed and funded by Lilly for UK healthcare professionals only. Lilly products will be discussed. Lilly has provided a sponsorship towards this conference, however, have had no input, control or influence over the agenda, speaker selections, presentations, or collateral content, except for this symposium session.

PP-TR-GB-1327 October 2025

Eimear Darcy and Roy Hamilton

14.50 – 15.25

Foot disease

Foot self-care
Spotting early warning signs
Foot checks and risk stratification
Screening in people with darker skin tones
When and how to refer

Debbie Sharman

15.25 – 16.00

Hot topics

Horizon scanning
Obesity drugs – what’s next?
Latest developments

Pam Brown

16.00

Chairs concluding remarks

Naresh Kanumilli

Speakers

Guruprasad Aithal

Professor of Hepatology, Nottingham Digestive Diseases Centre, Faculty of Medicine and Health Sciences, University of Nottingham

Sarah Alicea

Clinical Lead Diabetes Dietitian, Barts Health NHS Trust

Pam Brown

GP, Swansea

Professor James Burton

Professor of Renal Medicine and Honorary Consultant Nephrologist at the University of Leicester

Eimear Darcy

GP Partner, Omagh

Su Down

Diabetes Nurse Consultant, Somerset

Sheena Fraser

GP Partner, Waverley Park Medical Practice

Clare Hambling

GP, Norfolk and National Clinical Director for Diabetes and Obesity, NHS England

Roy Hamilton

GP Partner, Worcester

Dr Yassir Javaid

MA (Cantab) FRCP FRCGP PGDip Cardiology GPwSI Cardiology

Paul Kalra

Consultant Cardiologist, Portsmouth Hospitals University NHS Trust

Philip Kalra

Professor of Nephrology, University of Manchester

Naresh Kanumilli

GPwSI, Manchester and Chair of the PCDO Society

Professor Partha Kar

National Specialty Advisor, Diabetes with NHS England

Sarah le Brocq

Founder & Director All About Obesity

David Miller

Clinical Pharmacist in General Practice, Beverley

Nicola Milne

PCN DiaST Lead Diabetes Specialist Nurse Clinical Lead for the Greater Manchester Diabetes Clinical Network

David Morris

Retired GP & Specialist Doctor in Diabetes

Neil Munro

Retired GP

Kate O'Donnell

Professor of Primary Care Research and Development, University of Glasgow

Lisa Owens

Consultant Endocrinologist, St James’s Hospital, Dublin, Ireland

Dimitris Papamargaritis

Associate Professor and Honorary Consultant in Diabetes and Endocrinology, University of Leicester/ Kettering General hospital

Clair Ranns

Diabetes Specialist Pharmacist, NHS West Yorkshire Integrated Care Board

James Ridgeway

Research Associate/Diabetes Specialist Nurse

Debbie Sharman

Consultant Podiatrist, Dorset HealthCare University Trust

GOLD SPONSOR

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. Our approximately 54,500 employees serve over 130 markets to build a healthier and more sustainable tomorrow. Learn more at www.boehringer-ingelheim.com/uk

Silver SPONSORs

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.

At Abbott, we believe people with diabetes should enjoy active lives, so we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor glucose and providing healthcare professionals with more data to make better informed treatment decisions.

Home | Healthcare Professionals | FreeStyle | Abbott

At Dexcom, we believe that with diabetes, knowledge is power. We’ve spent the last 20 years innovating and developing simpler and better ways for people with type 1 diabetes to measure, track and manage their diabetes. When Dexcom was established the only way to measure glucose levels was to fingerstick, it gave us a snapshot not a story which made it difficult to understand our glucose levels and trends over time or feel in control of our diabetes. Since then, we’ve launched the world’s first real-time CGM system and helped to eliminate more than 11 billion fingersticks.

Lilly is a medicine company turning science into therapies to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world’s most significant health challenges.

We have been a global leader in diabetes since 1923, and are redefining diabetes and obesity care today. Through research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.

To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.

• Visit website →

• Request follow up →

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes.

To learn more, visit: https://www.novonordisk.co.uk/

STAND SPONSOR

Location

https://www.google.com/maps/embed?pb=!1m18!1m12!1m3!1d2431.9208392221035!2d-1.7088129246484174!3d52.44434874182945!2m3!1f0!2f0!3f0!3m2!1i1024!2i768!4f13.1!3m3!1m2!1s0x4870b1376449d76b%3A0x3f1e93fc0c5b6e72!2sNational%20Conference%20Centre%2C%20Coventry%20Rd%2C%20Hampton%20in%20Arden%2C%20Solihull%20B92%200EJ!5e0!3m2!1sen!2suk!4v1752135469979!5m2!1sen!2suk

National Conference Centre, Birmingham

Address: Coventry Road, Bickenhill, Solihull, West Midlands B92 0EJ

Venue link: https://www.nationalconferencecentre.co.uk/

Directions: The National Conference Centre is centrally situated at J6 on the M42 with excellent transport links to Birmingham International Airport and train station which is just a 5 minute drive away. Central Birmingham is 25 minutes drive.

Accommodation: Please click here for hotel rates

Coaches: Coach transfer will be available from the Hilton Metropole to the NCC on both mornings of the conference and on the return on day 1. After the conference on day 2 the coach will go to Birmingham International train station.

19 November 2025 09.00 - 17.20
20 November 2025 09.00 - 16.00

About

Why attend

Agenda

Speakers

Guruprasad Aithal

Sarah Alicea

Pam Brown

Professor James Burton

Eimear Darcy

Su Down

Sheena Fraser

Clare Hambling

Roy Hamilton

Dr Yassir Javaid

Paul Kalra

Philip Kalra

Naresh Kanumilli

Professor Partha Kar

Sarah le Brocq

David Miller

Nicola Milne

David Morris

Neil Munro

Kate O'Donnell

Lisa Owens

Dimitris Papamargaritis

Clair Ranns

James Ridgeway

Debbie Sharman

Sponsors

GOLD SPONSOR

Silver SPONSORs

STAND SPONSOR

Location